| 27th week of 2012 patent applcation highlights part 39 |
| Patent application number | Title | Published |
|---|
| 20120171071 | Ni3(Si, Ti)-BASED INTERMETALLIC COMPOUND TO WHICH Ta IS ADDED - The present invention provides a structural material having excellent hardness (strength) characteristics. | 2012-07-05 |
| 20120171072 | NANOWIRE PREPARATION METHODS, COMPOSITIONS, AND ARTICLES - Methods of preparing nanowires, and compositions and articles comprising the nanowires are disclosed. Such methods allow tailored synthesis of nanowires based on one or more product geometrical parameters. Such tailored nanowires are useful in electronic applications. | 2012-07-05 |
| 20120171073 | ALLOY FOR MAKING GROUNDING ELECTRODES AND CONNECTION METHOD THEREFOR - This invention refers to an alloy for the manufacture of ground-installed electrodes, which is primarily composed of aluminum, manganese, copper, zinc, cadmium, titanium, lead, and iron. This novel alloy allows for the manufacture of vertical and horizontal electrodes of different dimensions, which are used for the ground installation of electrical substations, transmission towers, and electrical distribution posts. In addition, the invention also provides a method to connect said electrodes in a more efficient manner. | 2012-07-05 |
| 20120171074 | METHOD AND APPARATUS FOR DESTRUCTION OF BIOLOGICAL AND CHEMICAL AGENTS - A device and method for inactivating infectious biological or chemical agents using microwave-activated diazoluminomelanin (DALM). The agents are typically vacuumed into a load cavity, which is at least partially filled with DALM. The load is irradiated with microwaves via a cylindrical waveguide disposed under the load cavity, thereby inactivating or destroying the agents. The system is preferably temperature controlled and operation is preferably automated. | 2012-07-05 |
| 20120171075 | Gamma And Temperature Hardened Pharmaceutical Devices - A system and method for implementing embedded electronics in environments where radiation or extreme temperatures are used is disclosed. Embedded electronics are affixed to various components of a pharmaceutical system, thereby enabling the customer to download pertinent information about the component, such as lot number, date of manufacturer, test parameters, etc. Additionally, these electronics allow an array of functions and features to be implemented, such as integrity tests and diagnostics. The electronics in the pharmaceutical components utilize a technology that is not as susceptible to radiation and extreme temperatures as traditional electronics. | 2012-07-05 |
| 20120171076 | WATER TEMPERATURE AS A MEANS OF CONTROLLING KINETICS OF ONSITE GENERATED PERACIDS - Methods and systems for temperature-controlled, on-site generation of peracids, namely peroxycarboxylic acids and peroxycarboxylic acid forming compositions are disclosed. In particular, methods for using an adjustable biocide formulator or generator system overcome the limitations of temperature on the kinetics of the peracid generation and/or peracid decomposition inside an adjustable biocide formulator or generator system. The methods include the controlling of the temperature of at least one raw starting material, namely water, to improve upon methods of on-site generation of peracids. The methods allow for the generation of user-selected chemistry without regard to the ambient temperatures of the raw starting materials and/or the biocide formulator or generator system. | 2012-07-05 |
| 20120171077 | System and method for decontamination - Systems and methods for decontaminating a facility, for example, in response to a biological attack. An exclusion zone, a support zone, and a contamination reduction zone may be established. The exclusion zone may have a suspected contaminant in one or more of its areas. The contamination reduction zone may be between the exclusion zone and the support zone. The exclusion zone may have an agent introduced into a pressurized environment within the exclusion zone to substantially eliminate the contaminant. A sample may be taken to determine the presence of the contaminant. | 2012-07-05 |
| 20120171078 | CUVETTE SUPPLYING DEVICE AND SPECIMEN ANALYZER - A cuvette supplying device is disclosed. The cuvette supplying device comprises: a cuvette storage for storing cuvettes; a carrier, provided inside the cuvette storage, for carrying the cuvettes in the cuvette storage outside the cuvette storage; a conveyor for conveying the cuvettes existing at the bottom of the cuvette storage towards the carrier; and an arranging section for arranging the cuvettes carried outside the cuvette storage by the carrier at a predetermined position. The specimen analyzer comprising the cuvette supplying device is also disclosed. | 2012-07-05 |
| 20120171079 | PHOTOCATALYST ELEMENT STRUCTURE, ULTRAVIOLET RADIATION AIR PURIFICATION SYSTEM, PHOTOCATALYST SHEET, AND METHOD OF MANUFACTURING PHOTOCATALYST SHEET - A photocatalyst element structure includes a photocatalyst element that includes a flat photocatalyst sheet and an undulating photocatalyst sheet overlapped on the flat photocatalyst sheet. The flat photocatalyst sheet and the undulating photocatalyst sheet include a porous titanium foil having a non-periodic spongy structure impregnated with anatase titanium dioxide particles. The photocatalyst element structure can include a plurality of the photocatalyst elements so that the flat photocatalyst sheet and the undulating photocatalyst sheet alternate. | 2012-07-05 |
| 20120171080 | Set-Up For Production Of Hydrogen Gas By Thermo-Chemical Decomposition Of Water Using Steel Plant Slag And Waste Materials - A system for the production of hydrogen from water in the presence of slag, comprising a graphite crucible containing molten slag; a reaction hood disposed over said crucible; a water line for spraying water on the molten slag in the crucible; and a steel tube for collecting and transferring the produced hydrogen gas from said hood into a condenser tank. | 2012-07-05 |
| 20120171081 | MOUNTING MAT - A mounting mat for a pollution control device is disclosed. The device comprises at least a first sheet and a second sheet and at least one holding means for holding the at least first and second sheets together. The holding means are adapted to (i) hold the at least first and second sheets together whilst allowing movement of the at least first and second sheets parallel to each other in the region where the holding means is positioned; and/or (ii) to break upon wrapping around a body thereby allowing movement of the at least first and second sheets parallel to each other in the region where the holding means is positioned. A pollution control device containing such a mat and method of making a pollution control device containing such a mat are also disclosed. | 2012-07-05 |
| 20120171082 | ELECTRIC HEATING CATALYST - The electricity is suppressed from flowing through a case of an electric heating catalyst. The electric heating catalyst comprises a heat generating element which generates heat by applying electricity; a case which accommodates the heat generating element; a mat which is provided between the heat generating element and the case and which insulates the electricity; and an inner tube which is provided on an inner side as compared with the case and on an outer side as compared with the heat generating element and which is supported by the mat while dividing the mat into a part disposed on a case side and a part disposed on a heat generating element side; wherein distances between the inner tube and the case are provided such that the distance is required to support the inner tube at a portion at which the mat exists, and the distance is required to avoid occurrence of any electric discharge between the inner tube and the case at a portion at which the inner tube protrudes from the mat. | 2012-07-05 |
| 20120171083 | APPARATUS FOR GENERATING HYDROGEN - An apparatus for generating hydrogen including a housing, a reservoir, and a piston is provided. The housing has a top wall, a bottom wall, and a sidewall. The top wall has vents and a protrudent column extending to the interior of the housing. At least one vent communicates with the top wall and the protrudent column and rest of the vents surround the protrudent column. The reservoir is disposed in the housing for storing a solid state reactant and divides the housing into a first chamber and a second chamber. The first chamber is located between the top wall and the reservoir. The second chamber is located between the bottom wall and the reservoir for storing a liquid reactant. The piston is disposed on the bottom wall. The piston is used to push the liquid reactant towards the reservoir to react with the solid state reactant to generate hydrogen. | 2012-07-05 |
| 20120171084 | GASIFICATION REACTOR FOR THE PRODUCTION OF CRUDE GAS - In the case of a gasification reactor for the production of crude gas, containing CO or H | 2012-07-05 |
| 20120171085 | DEVICE AND METHOD FOR TRANSPORTING MAGNETIC OR MAGNETISABLE BEADS - The present invention relates to a device ( | 2012-07-05 |
| 20120171086 | Separation Body for Three-Dimensional Chromatography - A separation body for three-dimensional chromatography, which provides at least one predefinable individual retention capacity in each spatial direction, for an analyte transported in a mobile phase in the respective direction. | 2012-07-05 |
| 20120171087 | Methods for Facilitating Fluid Flow Through Nanoporous Membranes - The present invention is drawn to methods for facilitating fluid flow through the nanopores of membranes, i.e., through sub-micron pores. The present invention is also directed to one or more apparatus for such fluid flow, and for nanoporous membranes modified to facilitate such fluid flow. | 2012-07-05 |
| 20120171088 | MULTI-WELL ROTARY SYNTHESIZER - An apparatus for synthesizing polymer chains includes a controller, a plurality of precision fit vials circularly arranged in multiple banks on a cartridge, a drain corresponding to each bank of vials, a chamber bowl, a plurality of valves for delivering reagents to selective vials, and a waste tube system for purging material from the vials. A purging operation can be selectively performed on one or more of the banks of vials. The plurality of vials are stored in the cartridge and are divided among individual banks wherein each bank of vials has a corresponding drain. There is at least one waste tube system for expelling the reagent solution from vials within a particular bank of vials when the waste tube system is coupled to the corresponding drain. The cartridge holding the plurality of vials rotates relative to the stationary banks of valves and the waste tube system. | 2012-07-05 |
| 20120171089 | NON-WOVEN FABRIC, METHOD FOR FABRICATING NON-WOVEN FABRIC, AND GAS GENERATION APPARATUS - A non-woven fabric for reacting with a liquid to produce a gas is provided. The non-woven fabric includes at least one non-woven fabric fiber, a plurality of hot melt particles, and a plurality of solid particles. The non-woven fabric fiber has a first melting point. The hot melt particles are bonded with the non-woven fabric fiber and have a second melting point, in which the first melting point is higher than the second melting point. At least a part of the solid particles are bonded with the hot melt particles. Moreover, a method for fabricating the non-woven fabric and a gas generation apparatus using the non-woven fabric are also provided. | 2012-07-05 |
| 20120171090 | CONTINUOUS TUBULAR FLOW REACTOR AND CORRUGATED REACTOR TUBE FOR THE REACTOR - The present invention provides a continuous tubular flow reactor which consists of a reactor tube module having an inlet port and an outlet port, and a pressuring device connected to the inlet port and the outlet of the reactor tube module. The reactor tube module comprises multiple reactor tubes butt connected in sequence. Each reactor tube has alternating straight sections and convergent-divergent sections, wherein inner diameter of the convergent-divergent section is smaller than that of the straight section. The pressuring device has a simple harmonic motion driving device. | 2012-07-05 |
| 20120171091 | METHOD OF MAKING PURE SALT FROM FRAC-WATER/WASTEWATER - The present invention relates to a method for making pure salt comprises recapturing post-drilling flowback water from hydro-fracturing; removing oil from the flowback water; filtering the flowback water using an ultra filter with a pore size of about 0.1 microns or less to remove solid particulates and large organic molecules, such as benzene, ethylbenzene, toluene, and xylene, from the water; concentrating the flowback water to produce a brine that contains from about 15 wt % to about 40 wt % of salt relative to the total weight of the flowback brine; performing one or more chemical precipitation process using an effective amount of reagents to precipitate out the desired high quality commercial products, such as, barium sulfate, strontium carbonate, calcium carbonate; and crystallizing the chemically treated and concentrated flowback brine to produce greater than 99.5% pure salt products, such as sodium and calcium chloride. | 2012-07-05 |
| 20120171092 | HIGH-EFFICIENCY, HOT TRAP APPARATUS AND METHOD - A hot trap for removing a reactive constituent gas from a gas stream via chemical reaction and/or thermal disassociation includes a trap chamber with a heater assembly and a trap medium in its core inner portion and annular pre-heating and counterflow heating ducts in its outer and intermediate portions surrounding the core inner portion for heating an inflowing gas stream and conservation of heat energy in the trap as well as to maintain lower temperatures on external surfaces. | 2012-07-05 |
| 20120171093 | COMPOSITIONS COMPRISING FUNCTIONALIZED CARBON-BASED NANOSTRUCTURES AND RELATED METHODS - The present invention generally relates to compositions comprising and methods for forming functionalized carbon-based nanostructures. | 2012-07-05 |
| 20120171094 | Aqueous solutions of amine functionalized ionic compounds for carbon capture processes - An aqueous ionic absorbent solution is disclosed containing (a) about 15 wt. % to about 80 wt. % of one or more diluents, based on the total weight of the aqueous ionic absorbent solution; and (b) an ionic absorbent containing a cation and an anion comprising an amine moiety. | 2012-07-05 |
| 20120171095 | LIQUID CARBON DIOXIDE ABSORBENTS, METHODS OF USING THE SAME, AND RELATED SYSTEMS - A carbon dioxide absorbent composition is described, including (i) a liquid, nonaqueous silicon-based material, functionalized with one or more groups that either reversibly react with CO | 2012-07-05 |
| 20120171096 | SYSTEMS AND METHODS FOR HIGH EFFICIENCY REGENERATIVE SELECTIVE CATALYTIC REDUCTION - The invention provides a system for regenerative selective catalytic reduction including a catalyst chamber that contains a catalyst for reducing NO | 2012-07-05 |
| 20120171097 | CATALYST FOR TREATING EXHAUST GASES, METHOD FOR PRODUCING THE SAME, AND METHOD FOR TREATING EXHAUST GASES - A catalyst for treating exhaust gases containing nitrogen monoxide, carbon monoxide and volatile organic compounds includes a plurality of layers, an upper layer of which has an active component contained uniformly therein and a lower layer of which has no active component contained therein. The catalyst is obtained through the steps of: forming the lower layer by coating the surface of substrate with a slurry of a porous inorganic compound, followed by drying; and forming the upper layer, which is to be the top surface of the catalyst, by coating the surface of the lower layer with a slurry of a porous inorganic compound that has the active component composed of one or more precious metals supported thereon, followed by drying. The oxidation power of the resulting catalyst is enhanced without increasing the amount of precious metal supported thereon. | 2012-07-05 |
| 20120171098 | METHOD OF CONSOLIDATING ULTRAFINE METAL CARBIDE AND METAL BORIDE PARTICLES AND PRODUCTS MADE THEREFROM - Ultrafine metal carbide or metal boride particles are consolidated by a method including sintering at intermediate pressures. A green body comprising the ultrafine metal carbide or metal boride particles may be preheated under vacuum and then pressurized to the intermediate sintering pressure. After sintering, the article may be densified at an intermediate temperature below the sintering temperature, and at an elevated pressure above the intermediate sintering temperature. The resultant consolidated metal carbide or metal boride article may then be cooled and used for such applications as armor panels, abrasion resistant nozzles, and the like. | 2012-07-05 |
| 20120171099 | PHOSPHORIC ACID PRODUCTION GYPSUM FILTRATION FLOCCULANT PRE-DILUTION (MAKE DOWN) WITH POST-FILTRATION PHOSPHORIC ACID - A method for minimizing the addition of water to a phosphoric acid production process is described. The method uses phosphoric acid to make down a flocculant that is added to the process in order to promote filtration or clarification of crude phosphoric acid. Preferably, the phosphoric acid is a crude, clarified phosphoric acid that is recycled from the phosphoric acid production process itself. | 2012-07-05 |
| 20120171100 | Process for hydrogenation of a silicon tetrahalide and silicon to trihalosilane - A process of hydrogenation of a silicon tetrahalide and silicon to a trihalosilane comprising: providing a vessel with at least one inlet and one outlet with a plurality of silicon particles located in a bed inside the vessel and feeding a mixture of gases consisting primarily of a silicon tetrahalide and hydrogen. A calculational procedure is provided where the flow rate of the gases and the incoming size of the silicon particulates are chosen so that at least 90% of the volume of the bed is free of bubbles after allowance for decrease in particle size due to the reaction and attrition resulting in a higher yield of the trihalosilane. | 2012-07-05 |
| 20120171101 | Recycling and Treatment Method of Waste Liquid in Cutting Mono Silicon - A recycling and treatment method of mono silicon's cutting waste liquid, which includes the following steps: 1. treat the waste liquid with diluted hydrochloric acid, then stir into an easy-to-flow mixture; 2. heat up the mixture for solid-liquid separation, such that water and polyethylene glycol are evaporated, condensed and dehydrated to recover the polyethylene glycol, and obtain coarse solid mixture of silicon carbide and silicon; 3. obtain the secondary solid mixture of silicon carbide and silicon by secondary cleaning of the coarse solid mixture with water; 4. recycle silicon and silicon carbide by treatment with the mixed acid solution of HN0 | 2012-07-05 |
| 20120171102 | FLUIDIZED BED REACTOR FOR PRODUCTION OF HIGH PURITY SILICON - Methods and apparatus for the production of high purity silicon including a fluidized bed reactor with one or more protective layers deposited on an inside surface of the fluidized bed reactor. The protective layer may be resistant to corrosion by fluidizing gases and silicon-bearing gases. | 2012-07-05 |
| 20120171103 | METHOD FOR MODIFYING ELECTRICAL PROPERTIES OF CARBON NANOTUBES - The invention relates to a method of modifying electrical properties of carbon nanotubes by subjecting a composition of carbon nanotubes to one or more radical initiator(s). The invention also relates to an electronic component such as field-effect transistor comprising a carbon nanotube obtained using the method of the invention. The invention also relates to the use of the modified carbon nanotubes in conductive and high-strength nanotube/polymer composites, transparent electrodes, sensors and nanoelectromechanical devices, additives for batteries, radiation sources, semiconductor devices (e.g. transistors) or interconnects. | 2012-07-05 |
| 20120171104 | PROCESS FOR PRODUCING DISPERSION OF SURFACE-TREATED CARBON BLACK POWDER, AND PROCESS FOR PRODUCING SURFACE-TREATED CARBON BLACK POWDER - A method of producing a surface-treated carbon black powder dispersion includes subjecting carbon black fine particles having a volume average particle size of 100 nm to 20 μm to wet granulation and drying by heating to obtain granulated carbon black having a hardness of 12 cN or less and a pH of less than 7, grinding the granulated carbon black to obtain a ground product having a volume average particle size of 20 nm to 20 μm, and subjecting the ground product to wet oxidization in an aqueous medium. The resulting surface-treated carbon black powder dispersion exhibits excellent print density, print quality, discharge stability, and storage stability when used as an inkjet printer aqueous black ink. | 2012-07-05 |
| 20120171105 | METHOD FOR IMPROVING TOTAL ENERGY DEMAND IN A POST-COMBUSTION CARBON CAPTURE PROCESS WITH IONIC ABSORBENT - Disclosed herein is a method for improving the total energy demand required to separate carbon dioxide (CO | 2012-07-05 |
| 20120171106 | CARBON NANOTUBE GROWTH VIA CHEMICAL VAPOR DEPOSITION USING A CATALYTIC TRANSMEMBRANE TO SEPARATE FEEDSTOCK AND GROWTH CHAMBERS - A system and method for growing nanotubes out of carbon and other materials using CVD uses a catalytic transmembrane to separate a feedstock chamber from a growth chamber and provide catalytic material with separate catalytic surfaces to absorb carbon atoms from the feedstock chamber and to grow carbon nanotubes in the growth chamber. The catalytic transmembrane provides for greater flexibility to independently control both the gas environment and pressure in the chambers to optimize absorption and carbon growth and to provide instrumentation in the growth chamber for in-situ control of defects or observation of the carbon nanotube growth. | 2012-07-05 |
| 20120171107 | METHOD OF FORMING SINGLE-WALLED CARBON NANOTUBES - The present invention relates to a method of forming single-walled carbon nanotubes. The method comprises contacting a gaseous carbon source with mesoporous TUD-1 silicate at suitable conditions. The mesoporous TUD-1 silicate comprises a metal of groups 3-13 of the Periodic Table of the Elements. | 2012-07-05 |
| 20120171108 | METHOD FOR FABRICATING GRAPHENE SHEETS OR GRAPHENE PARTICLES USING SUPERCRITICAL FLUID - A method for fabricating graphene sheets or graphene particles includes (a) dispersing graphene oxide in an alcohol solution to prepare a graphene oxide dispersion solution, (b) reducing the graphene oxide dispersion solution under a supercritical condition to prepare graphene sheets or graphene particles, each of which is as a cluster of the graphene sheets, and (c) separating the graphene sheets or graphene particles, followed by washing and drying, and a method for fabricating a graphene film is configured to fabricate a graphene film in form of a thin film using the graphene sheets or graphene particles fabricated according to the method. | 2012-07-05 |
| 20120171109 | RANDOM GRAPHITE AND FABRICATION METHOD THEREOF USING GRAPHENE NANORIBBON - Random graphite which is a type of graphite comprising three-dimensionally random graphene layers, and a fabrication method thereof at a low temperature as below 100° C. are disclosed. Random graphite may have a large volume of an empty space due to the feature of the presence of the three-dimensionally random graphene nanoribbons. Thus, it can be applied to Graphitic Intercalation Compound (GIC) such as electrodes for Li-ion battery. | 2012-07-05 |
| 20120171110 | METHOD AND SYSTEM FOR THE PRODUCTION OF SULFURIC ACID - The invention relates to a method and an installation for producing sulfuric acid. First of all, a product gas flow ( | 2012-07-05 |
| 20120171111 | PROCESS FOR PRODUCTION OF OXIDATION REACTION PRODUCT OF AROMATIC COMPOUND - The present invention provides a process for producing an oxidation reaction product of an aromatic compound, having excellent environmental load reduction performance, cost reduction performance, etc. Provided is a process for producing an oxidation reaction product of a raw material aromatic compound by reacting the raw material aromatic compound with an oxidizing agent. The process further uses an electron donor-acceptor linked molecule. The process includes the step of: reacting the electron donor-acceptor linked molecule in an electron-transfer state, the oxidizing agent, and the raw material aromatic compound, thereby generating an oxidation reaction product resulting from oxidation of the raw material aromatic compound. | 2012-07-05 |
| 20120171112 | TITANIUM OXIDE NANO TUBE MATERIAL AND METHOD FOR MANUFACTURING THE SAME - A titanium oxide nano tube material is configured so that crystal grains of a nano tube has a crystal structure oriented with the [001] direction of a tetragonal crystal system as a preferred direction. FWHM (Full Width at Half Maximum) of a rocking curve with respect to the (004) plane peak is 11.1 degrees to 20.3 degrees. The titanium oxide nano tube material has excellent photoelectric characteristics since the crystal grains of the nano tube are oriented with the (004) plane or the [001] direction of a tetragonal crystal system as a preferred direction. | 2012-07-05 |
| 20120171113 | PROCESS FOR THE PREPARATION OF TITANIUM DIOXIDE HAVING NANOMETRIC DIMENSIONS AND CONTROLLED SHAPE - The present invention relates to a process for the preparation of materials with nanometric dimensions and controlled shape, based on titanium dioxide. The invention also relates to a process for the preparation of titanium dioxide nanorods and nanocubes with anatase phase composition, which are highly suitable for photocatalytic use, in particular for applications involving photovoltaic cells, for example Dye Sensitized Solar Cells (DSSC), photoelectrolysis cells and tandem cells for the conversion of solar energy and the production of hydrogen. | 2012-07-05 |
| 20120171114 | ANTI-CD151 ANTIBODIES AND THEIR USE IN THE TREATMENT OF CANCER - The present invention relates to new antibodies capable of binding specifically to the human CD151 protein, especially monoclonal antibodies of murine origin, which are chimeric and humanised, and also to the amino acid and nucleic sequences coding for those antibodies. The invention also includes use of those antibodies as medicaments for the prophylactic and/or therapeutic treatment of cancers and in diagnostic methods or kits for diseases associated with overexpression of the CD151 protein. Finally, the invention includes products and/or compositions comprising such antibodies in association with antibodies and/or anti-cancer agents or conjugated with toxins and/or radioelements and their use in the prevention and/or treatment of certain cancers. | 2012-07-05 |
| 20120171115 | IMMUNO-CONJUGATES AND METHODS FOR PRODUCING THEM - The present invention provides an isolated protein comprising an immunoglobulin variable region comprising at least two cysteine residues positioned within framework region (FR) 2 and/or at least two cysteine residues positioned within framework region (FR3), wherein if at least two of the cysteine residues in FR2 and/or FR3 are not conjugated to a compound then an intra-framework disulphide bond is capable of forming between the cysteine residues. Preferably the protein comprises an immunoglobulin heavy chain variable region (V | 2012-07-05 |
| 20120171116 | Arginase Inhibitors and Methods of Use Thereof - The present invention includes arginase enzyme inhibitors, compositions comprising these arginase inhibitors, and methods of treating or diagnosing conditions characterized either by abnormally high arginase activity or abnormally low nitric oxide levels in a mammal, comprising administering compositions of the invention to the mammal. | 2012-07-05 |
| 20120171117 | RADIOFLUORINATED COMPOUNDS AND THEIR PREPARATION - The present invention provides a process for [ | 2012-07-05 |
| 20120171118 | TREATMENT OF MENINGEAL AND NEURAL DISEASES - The present invention provides conjugates and methods of using the same for the treatment of cerebral, meningeal, and neural diseases, disorders, and conditions. Provided methods include administering conjugates directly into the cerebrospinal fluid space of an animal. | 2012-07-05 |
| 20120171119 | PEGYLATED FLUOROBENZAMIDE ANALOGUES, THEIR SYNTHESIS AND USE IN DIAGNOSTIC IMAGING - Pegylated fluoroalkoxybenzamide compounds which selectively bind Sigma-2 receptors are disclosed. These compounds, when labeled with a positron-emitting radioisotope such as | 2012-07-05 |
| 20120171120 | LOW AFFINITY BLOOD BRAIN BARRIER RECEPTOR ANTIBODIES AND USES THEREFOR - The present invention relates to antibodies that bind blood brain barrier receptors (BBB-R) and methods of using the same. | 2012-07-05 |
| 20120171121 | Rosette Nanotubes as Drug Delivery Agents - The present invention is directed to delivery complexes of rosette nanotubes and one or more biologically active agents or diagnostic agents. | 2012-07-05 |
| 20120171122 | Loop-Variant Pdz Domains As Biotherapeutics, Diagnostics And Research Reagents - The present invention provides polypeptides that contain one or more PDZ loop-variants and are useful in the detection of pathogens and disease-associated molecules. The polypeptides of the invention are also useful in the diagnosis, treatment, and prevention of diseases. Also provided are methods of preparing polypeptides of the invention. | 2012-07-05 |
| 20120171123 | USES AND COMPOSITIONS FOR TREATMENT OF RHEUMATOID ARTHRITIS - The invention provides methods, uses and compositions for the treatment of rheumatoid arthritis. The invention describes methods and uses for treating rheumatoid arthritis wherein a TNFα inhibitor, such as a human TNFα antibody, or antigen-binding portion thereof. Also described are methods for determining the efficacy of a TNFα inhibitor for treatment of rheumatoid arthritis in a subject. | 2012-07-05 |
| 20120171124 | SCREENING METHODS FOR COGNITIVE ENHANCERS - The present invention provides methods for identifying cognitive enhancers able to enhance CREB pathway function. Cognitive enhancers identified in accordance with the invention can be used in rehabilitating an animal with cognitive dysfunctions and for enhancing memory or normal cognitive performance (ability or function) in a normal animal. | 2012-07-05 |
| 20120171125 | Methods for Enhancing the Cognitive Function - A compound having an affinity to a SV2 protein for the treatment of a condition associated with enhancement or improvement of the cognitive ability or to counteract cognitive decline of a mammal. For example, a compound which is covered by formula (I) R | 2012-07-05 |
| 20120171126 | NOVEL [3,2-c] HETEROARYL STEROIDS AS GLUCOCORTICOID RECEPTOR AGONISTS COMPOSITIONS AND USES THEREOF - The present invention provides compounds of Formula (I), and pharmaceutically acceptable salts, solvates, esters, prodrugs, tautomers, or isomers of said compounds), having the general structure: Formula (I) wherein L, R | 2012-07-05 |
| 20120171127 | VOC-FREE COMPRESSED GAS AEROSOL COMPOSITION - Certain surfactants suitable for use alone to dissolve a water-insoluble component in compositions is described for providing VOC-free compressed gas aerosol compositions. The compositions include water-insoluble component(s), a surfactant and water. The water-insoluble component(s) can be active agent(s), such as fragrance(s) and/or an insecticide(s). The surfactant is present as a single surfactant which, in the absence of a solvent, dissolves or disperses the water-insoluble component(s) and provides a homogenous blend in water which provides a stable compressed gas emulsion. The surfactant is an anionic surfactant or a nonionic surfactant, in particular nonionic alkylpolyglycosides; nonionic cocoglucoside; nonionic alkylene oxide extended chain alkylpolyglycosides; anionic sodium lauryl ether sulfate (SLES), nonionic C | 2012-07-05 |
| 20120171128 | DENTAL CLEANING COMPOSITION - Provided are dental cleaning compositions, methods of using and methods of using such compositions which minimize gum damage in the oral cavity. In one form, the dental cleaning composition includes a substantially stoichiometric ratio of one or more oxidizing agents to one or more reducing agents in one or more one or more orally acceptable carriers; where the substantially stoichiometric ratio of one or more oxidizing agents to one or more reducing agents is sufficient to neutralize the oxidizing agent in a subject oral cavity; and where the one or more oxidizing agents and one or more reducing agents are either co-dispensed or sequentially dispensed in the subject oral cavity. | 2012-07-05 |
| 20120171129 | Inhibition and Dispersion of Bacterial Biofilms with Benzimidazole Derivatives - Disclosure is provided for benzimidazole derivative compounds that prevent, remove and/or inhibit the formation of biofilms, compositions including these compounds, devices including these compounds, and methods of using the same. | 2012-07-05 |
| 20120171130 | Mitigation of Animal and Plant Diseases Using Bioavailable Minerals - A composition is able to treat plant and animal diseases and includes a therapeutically effective amount of an encapsulated ionic mineral complex and a pharmaceutically acceptable carrier. The composition may also include other inert ingredients, botanical extracts and vitamin and mineral supplements. | 2012-07-05 |
| 20120171131 | Cosmetic Composition - Provided are cosmetic and personal care compositions having film-formers that are copolymers of olefins and cycloolefins, such as ethylene/propylene/ethylidenenorbornene terpolymers. The compositions may provide long wearing, transfer resistant and/or highly comfortable films on the lips, skin, hair and nails. | 2012-07-05 |
| 20120171132 | COMPOSITION CONTAINING AN ALKOXYSILANE AND HYALURONIC ACID - A composition comprising: at least one alkoxysilane having at least one solubilizing functional group and at least one amino substituent; at least one glycosaminoglycan chosen from hyaluronic acid; water; optionally, at least one auxiliary ingredient; and optionally, at least one volatile solvent. | 2012-07-05 |
| 20120171133 | Modulation of Dynein in Skin - Methods for preventing, ameliorating, or reducing dermatological signs of aging are provided which employ active agents that modulate dynein expression in the skin. Also provided are methods for screening for substances which modulate dynein expression levels and the methods of using active agents identified by the screening protocol in the treatment of skin. | 2012-07-05 |
| 20120171134 | COMPOSITION COMPRISING A TOCOPHEROL PHOSPHATE AND PREPARATION PROCESS - The invention relates to an aqueous solution comprising at least one tocopherol phosphate or one of its salts, at least one non-ionic surface-active agent and at least one diol. | 2012-07-05 |
| 20120171135 | Gentle Dyeing and Lightening Agents Having Improved Lightening Power - Cosmetics for oxidatively dyeing and/or lightening keratin fibers, especially human hair, containing, in a cosmetic carrier, at least one oxidant chosen from hydrogen peroxide and/or the solid addition products thereof attaching to inorganic or organic compounds, at least one alkanolamine of formula (I), NH | 2012-07-05 |
| 20120171136 | Pressed Powder Cosmetic Composition - To provide a pressed powder cosmetic composition excellent in impact resistance, or a pressed powder cosmetic composition satisfying both impact resistance and good feeling in use. A pressed powder cosmetic composition comprising oily ingredients in an amount of from 1 to 20% by mass and powder ingredients in an amount of from 80 to 99% by mass, wherein the oily ingredients include di(isostearyl/phytosteryl) dimer dilinoleate; or the pressed powder cosmetic composition which contains di(isostearyl/phytosteryl) dimer dilinoleate in a ratio of from 0.5 to 15% by mass in the total amount of the cosmetic composition. | 2012-07-05 |
| 20120171137 | COMFORTABLE, LONG-WEARING, TRANSFER-RESISTANT COLORED COSMETIC COMPOSITIONS HAVING A NON-TACKY FEEL - The present invention is directed to an anhydrous composition which is long wearing and transfer resistant, while at the same time providing superior comfort, non-tacky feel and cushioning, the composition containing:(a) at least one silsesquioxane resin; (b) at least one polypropylsilsesquioxane wax substituted with alkyl units having at least 30 carbons; (c) at least one siloxysilicate resin; (d) at least one volatile solvent; (e) optionally, at least one non-volatile solvent; and (f) at least one colorant. | 2012-07-05 |
| 20120171138 | COMFORTABLE, LONG-WEARING, TRANSFER-RESISTANT COLORED COSMETIC COMPOSITIONS HAVING HIGH GLOSS AND A NON-TACKY FEEL - The present invention is directed to an anhydrous glossy composition which is long wearing and transfer resistant, while at the same time providing superior comfort, non-tacky feel and cushioning, the composition containing (a) at least one siloxysilicate resin; (b) at least one polyorganosiloxane-containing polymer; (c) at least one volatile solvent; (d) at least one non-volatile solvent having more than one phenyl group; and (e) optionally, at least one colorant; and wherein the ratio by weight of (b) to (a) is greater than or equal to 1. | 2012-07-05 |
| 20120171139 | COMFORTABLE, LONG-WEARING, TRANSFER-RESISTANT COLORED COSMETIC COMPOSITIONS - The present invention is directed to an anhydrous composition which is long wearing and transfer resistant, while at the same time providing superior comfort, feel and cushioning, the composition containing: (a) at least one polypropylsilsesquioxane wax substituted with alkyl units having at least 30 carbons; (b) at least one siloxysilicate resin; (c) at least one polyorganosiloxane-containing polymer; (d) at least one volatile solvent; (e) optionally, at least one non-volatile solvent; and (f) at least one colorant. | 2012-07-05 |
| 20120171140 | REACTION PRODUCT OF A POLAR MODIFIED POLYMER AND AN ALKOXYSILANE AND A COMPOSITION CONTAINING THE REACTION PRODUCT - The invention relates to a reaction product of a polar modified polymer and an alkoxysilane having at least one solubilizing functional group and at least one amino substituent. | 2012-07-05 |
| 20120171141 | EMULSIONS CONTAINING A MICRONIZED WAX - The invention relates to a composition comprising at least one micronized wax which, if desired, can be processed at room temperature. | 2012-07-05 |
| 20120171142 | COMPOSITIONS CONTAINING A MICRONIZED WAX - The invention relates to a composition comprising at least one oil-dispersible micronized wax which, if desired, can be processed at room temperature. | 2012-07-05 |
| 20120171143 | WATER-FREE ANTIPERSPIRANT SPRAYS IN WHICH ACTIVE SUBSTANCES ARE MORE READILY RELEASED - Antiperspirant compositions for personal body care which are produced as a suspension or solution that can be sprayed with or without using a propellant include at least one antiperspirant, at least one oil as a carrier, the oil being liquid in normal conditions, 0-7 percent by weight of free water relative to the weight of the composition, and at least one selected alkyl-modified polyether. | 2012-07-05 |
| 20120171144 | METHODS OF TREATING, REDUCING AND INHIBITING THE APPEARANCE OF AGEING IN THE SKIN - Methods of treating, reducing and inhibiting the appearance of ageing in the skin are provided. Also provided are uses and methods of maintaining a youthful appearance, reducing an appearance of ageing, inhibiting an appearance of ageing, reducing a rate of an appearance of ageing, reducing a skin inelasticity, reducing a rate of increasing skin inelasticity, maintaining a skin elasticity, and increasing the density of hair follicles of a skin of a subject comprising applying a granzyme B inhibitor to the skin of the subject. Also provided are methods of identifying a granzyme B inhibitors and agonists. | 2012-07-05 |
| 20120171145 | MASCARA COMPOSITIONS CONTAINING AN OIL-DISPERSIBLE MICRONIZED WAX - The invention relates to a mascara composition comprising at least one micronized wax. | 2012-07-05 |
| 20120171146 | Shear Thickening Cleansing Composition - The present invention is related to an aqueous cleansing composition for keratin fibres especially human hair with shear thickening property. Specifically, present invention is on cleansing compositions for keratin fibres, especially for human hair, based on at least one anionic surfactant, especially anionic sulphate surfactant, at a concentration of 2 to 25% by weight, and further comprising at least one amino acid surfactant, and at least one ethoxylated monoglyceride. | 2012-07-05 |
| 20120171147 | SILICONE EMULSIONS, AND METHODS FOR THE PRODUCTION THEREOF - Emulsions of high viscosity silicones are prepared by emulsifying a lower viscosity condensable silicone with a partial phosphate ester surfactant, and ripening the emulsion to obtain a higher viscosity silicone dispersed phase without generation of objectional amounts of octaorganocyclotetrasiloxanes. The emulsions are well suited for body care products. | 2012-07-05 |
| 20120171148 | HAIR CARE COMPOSITION - (1) The invention provides a composition for hair that imparts to the hair such properties as moist feeling, the feel of smoothness, thick-film touch, and ease of combing. These properties are long lasting and do not disappear after repeated brushing. | 2012-07-05 |
| 20120171149 | AGENTS FOR TREATING KERATIN FIBERS, CONTAINING DIMETHYLSILANOL HYALURONATES AND GLYCEROL - A hair treatment agent includes dimethylsilanol hyaluronates and glycerol. | 2012-07-05 |
| 20120171150 | Ion Bonding Pharmaceutical Composition - A pharmaceutical composition is provided that is useful for reducing sodium in the bloodstream of animals. In some embodiments, the pharmaceutical composition comprises a high-ion-affinity part and a substrate part. Additionally, methods of using the pharmaceutical composition and methods of treating diseases with the pharmaceutical composition are disclosed. | 2012-07-05 |
| 20120171151 | MASS SPECTROMETRIC QUANTITATION ASSAY FOR METABOLITES OF LEFLUNOMIDE - Methods are described for determining the amount of metabolites of leflunomide in a sample. More specifically, mass spectrometric methods are described for detecting and quantifying teriflunomide in a sample. | 2012-07-05 |
| 20120171152 | Amphiphilic Polymer-Protein Conjugates and Methods of Use Thereof - Compositions and methods for transporting biologically active proteins and polypeptides, particularly across the blood-brain barrier, are provided. | 2012-07-05 |
| 20120171153 | Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions - Provided are combinations, compositions and kits containing a hyaluronan degrading enzyme, such as a soluble hyaluronidase, for treatment of hyaluronan-associated conditions, diseases and disorders. In one example, the products include an additional agent or treatment. Such products can be used in methods for administering the products to treat the hyaluronan-associated diseases and conditions, for example, hyaluronan-associated cancers, for example, hyaluronan-rich tumors. The methods include administration of the hyaluronan degrading enzyme composition alone or in combination with other treatments. Also provided are methods and compositions for providing sustained treatment effects in hyaluronan-associated diseases and conditions. | 2012-07-05 |
| 20120171154 | PURIFICATION OF MULTI-SPECIFIC RECEPTORS - Disclosed is a method for preparing a composition enriched for receptors (typically molecular impringet polymers, MIPs) that bind an agent, where said receptors each specifically bind at least two discrete sites on said agent, by subjecting a sample of receptors to a first step of affinity purification with the agent where one binding site on the agent is non-accessible for binding to the receptors and subsequently subjecting the purified receptors to at least one further step of affinity purification with the agent where a second binding site on the agent is non-accessible. Also disclosed is a method for treatment, amelioration or prophylaxis of a disease selected from the group consisting of phenylketonuria (PKU, Følling's disease), hyperphenylalaninemia (HPA), alcaptonuria (black urine disease), tyrosinemia, hypertyrosinemia, myasthenia gravis, histidinemia, urocanic aciduria, maple syrup urine disease (MSUD), isovaleric acidemia (isovaleryl-CoA dehydrogenase deficiency), homocystinuria, propionic acidemia, methylmalonic acidemia, and glutaric aciduria Type 1 (GA-I), galactosemia, comprising administering to the gastrointestinal tract of a patient in need thereof an effective amount of a composition of molecular imprinted polymers (MIPs), said composition being capable of binding a symptom provoking agent of said disease. | 2012-07-05 |
| 20120171155 | Durable Antimicrobial Composition - The present invention relates to compositions having durable antimicrobial activity. The compositions include a carbonate/bicarbonate salt of a quaternary ammonium cation, an organic acid, hydrogen peroxide and a polymer. The polymer is selected from cationic amine polymer-epichlorohydrin adduct, cationic amine polymer-epichlorohydrin resin, poly(methacrylamidopropyltrimethylammonium)chloride, poly(bis(2-chloroethyl)ether-alt-1,3-bis(dimethylamino)propyl)urea, poly(diallyldimethylammonium)chloride, poly(t-butyl acrylate co-ethyl acrylate co-methacrylic acid), polyethylene oxide, polyquaternium-16, polyquaternium-22, polyquaternium-67 and mixtures thereof. | 2012-07-05 |
| 20120171156 | METHODS AND COMPOUNDS FOR REDUCING ALLERGIC REACTIONS TO HAIR DYES - Conventional commercial hair dyes form potent allergens and may also have irritant properties. If they were not already well established in the market and the side effects tolerated by consumers they would likely be deemed unsafe for use. The invention relates to compounds, compositions, formulations and methods for reducing, avoiding or eliminating allergic contact dermatitis reactions to conventional commercial hair dyes. | 2012-07-05 |
| 20120171157 | Macrocyclic Inhibitors Of Hepatitis C Virus - Inhibitors of HCV replication of formula (I) | 2012-07-05 |
| 20120171158 | METHODS OF USING sIP-10, CD26 INHIBITORS AND CXCR3 LEVELS IN A SAMPLE TO ASSESS CLEARANCE OF INFECTION, RESPONSE TO INTERFERON THERAPY, AND TREATING CHRONIC INFECTIONS - The present invention relates to methods for the treatment of infection, a disease, or a condition using CD26 (DPIV) inhibitors. The present invention also relates to an antibody that binds to the IP-10 protein and a method of monitoring the necessity for administering a CD26 inhibitor to a patient, comprising evaluating a level of sIP-10, a activity of CD26, and/or a level of CXCR3 cells in a sample. | 2012-07-05 |
| 20120171159 | NON-PATHOGENIC AND/OR ATTENUATED BACTERIA CAPABLE OF INDUCING APOPTOSIS IN MACROPHAGES, PROCESS OF MANUFACTURING AND USES THEREOF - The invention relates to an non-pathogenic and/or attenuated bacterium which is capable of inducing apoptosis in macrophages. | 2012-07-05 |
| 20120171160 | EXPRESSION OF VIRUS ENTRY INHIBITORS AND RECOMBINANT AAV THEREFOR - The present invention relates generally to the use of recombinant adeno-associated viruses (rAAV) for gene delivery and more specifically to the use of rAAV to deliver genes encoding human immunodeficiency virus entry inhibitors to target cells in mammals. | 2012-07-05 |
| 20120171161 | COMPOSITIONS COMPRISING PLACENTAL STEM CELLS AND PLATELET RICH PLASMA, AND METHODS OF USE THEREOF - Provided herein are compositions comprising placental stem cells and platelet rich plasma. Also provided herein are methods of treating an individual suffering from a disease or condition that would benefit from reduced inflammation, promotion of angiogenesis, and enhanced healing, comprising administering a therapeutically effective amount of a composition comprising placental stem cells and platelet rich plasma, as described herein, to said individual in an amount and for a time sufficient for detectable improvement of said disease or condition. | 2012-07-05 |
| 20120171162 | FERMENTED FOOD PRODUCTS CONTAINING PROBIOTIC STRAINS, AND METHOD FOR PREPARING SAME - The use of at least one sulphur-containing amino acid, at a total concentration of about 5 to 75 mg/ml, in particular of about 5 to about 50 mg/l, in particular of about 5 to about 30 mg/l, in particular of about 5 to about 20 mg/l, in free form, for implementing a method for preparing a fermented food product fermented by ferments containing bifidobacteria, the food product has acceptable sensory properties, contains more than about 5×10 | 2012-07-05 |
| 20120171163 | METHOD FOR INHIBITING A BACTERIAL INVASIVE MECHANISM USING A NUTRITIONAL COMPOSITION - A method for inhibiting a bacterial invasive mechanism involving administering to a human a nutritional composition including a lipid or fat; a protein source; about 5 to about 100 mg/100 kcal of a source of long chain polyunsaturated fatty acids which comprises docosahexanoic acid; about 0.1 to about 1 g/100 kcal of a prebiotic composition, wherein the prebiotic composition comprises at least 20% of an oligosaccharide; at least about 10 mg/100 kCal of lactoferrin selected from the group consisting of non-human lactoferrin, human lactoferrin produced by a genetically modified organism, and combinations thereof. | 2012-07-05 |
| 20120171164 | USE OF NUTRITIONAL COMPOSITIONS INCLUDING LACTOFERRIN IN SUPPORTING RESISTANCE TO VIRAL RESPIRATORY TRACT INFECTIONS - The present disclosure relates to the use of nutritional compositions including lactoferrin in supporting resistance to a viral respiratory tract infection. The method includes administering to a human a nutritional composition comprising a fat or lipid source, a protein source and lactoferrin produced by a non-human source. | 2012-07-05 |
| 20120171165 | HUMAN MILK OLIGOSACCHARIDES TO PROMOTE GROWTH OF BENEFICIAL BACTERIA - Disclosed are nutritional compositions including human milk oligosaccharides that can be administered to individuals including preterm infants, infants, toddlers, and children for improving gastrointestinal function and tolerance, as well as the growth of beneficial bacteria. Additional suitable methods of using the nutritional compositions including the human milk oligosaccharides are also disclosed. | 2012-07-05 |
| 20120171166 | SYNBIOTIC COMBINATION OF PROBIOTIC AND HUMAN MILK OLIGOSACCHARIDES TO PROMOTE GROWTH OF BENEFICIAL MICROBIOTA - Disclosed are nutritional compositions including human milk oligosaccharides that can be administered to individuals including preterm infants, infants, toddlers, and children for improving gastrointestinal function and tolerance, as well as the growth of beneficial microbiota. Suitable additional methods of using the nutritional compositions including the human milk oligosaccharides are also disclosed. | 2012-07-05 |
| 20120171167 | ANTI-OBESITY AGENT, ANTI-OBESITY FOOD OR BEVERAGE, GLUCOSE TOLERANCE-AMELIORATING AGENT, AND FOOD OR BEVERAGE FOR AMELIORATION OF GLUCOSE TOLERANCE - An anti-obesity agent or a glucose tolerance-ameliorating agent containing a bacterium belonging to the genus | 2012-07-05 |
| 20120171168 | METHOD FOR TREATING PANCREATITIS WITH MESENCHYMAL STEM CELLS - The present application discloses a method of treating pancreatitis by administering to the patient mesenchymal stem cells that are obtained by manipulating a biological sample of cells, which includes multi-lineage stem cells, progenitor cells, other marrow stromal cells: allowing the sample of cells to settle in a container; transferring supernatant from the container to another container; and isolating cells from the supernatant, which has comparatively lower density in the sample. | 2012-07-05 |
| 20120171169 | COMPOSITIONS AND METHODS FOR TREATING, PREVENTING, OR ALLEVIATING BONE OR CARTILAGE DISEASES - The present invention provides pharmaceutical compositions, methods of preparations, and uses for treatments, preventions or alleviation of bone and cartilage diseases. The present invention discloses methods and pharmaceutical compositions comprising adipose tissue-derived stem cells, platelet rich plasma, calcium chloride, and hyaluronic acid for the treatments, preventions, or alleviation of bone diseases; methods and a pharmaceutical compositions further comprising of dexamethasone for treatments, preventions, or alleviation of cartilage diseases. | 2012-07-05 |
| 20120171170 | TREATMENT OF COLLAGEN GENE RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO A COLLAGEN GENE - The present invention relates to antisense oligonucleotides that modulate the expression of and/or function of a Collagen gene, in particular, by targeting natural antisense polynucleotides of a Collagen gene. The invention also relates to the identification of these antisense oligonucleotides and their use in treating diseases and disorders associated with the expression of Collagen genes. | 2012-07-05 |
